Register information Patent

DE file number : 60 2009 061 852.0 (Status: pending/in force, Query started: May 4, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INID	Criterion	Field	Content
	Type of IP right	SART	Patent
	Status	ST	Pending/in force
21	DE file number	DAKZ	60 2009 061 852.0
96	EP file number	EAKZ	17 19 5757.4
97	EP publication number	EPN	3348573
54	Designation/title	TI	METHODE ZUR HERSTELLUNG VON ANTIKÖRPER GEGEN FCRN
51	IPC main class	ICM (ICMV)	C07K 16/28 (2006.01)
51	IPC secondary class(es)	ICS (ICSV)	A61P 37/00 (2006.01)
22	DE application date	DAT	Apr 24, 2009
96	EP application date	EAT	Apr 24, 2009
43	Date of first publication	OT	Jul 18, 2018
	Date of publication of grant	PET	Apr 22, 2020
71/73	Applicant/owner	INH	Bioverativ Therapeutics Inc., Waltham, Mass., US; Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
72	Inventor	IN	TENHOOR, Christopher, Hopkinton, MA 01748, US; MURUGANANDAM, Arumugam, 560035 Bangalore, IN; LADNER, Robert, Charles, Ijamsville, MD 21754, US; WOOD, Clive, 55218 Ingelheim am Rhein, DE; BITONTI, Alan, J., Waltham, MA 02451, US; STATTEL, James, Hagerstown, MD 21740, US; MCDONNELL, Kevin, Waltham, MA 02451, US; LIU, Liming, Upper Dublin, PA 19002, US; DUMONT, Jennifer, Groton, MA 01450, US; SATO, Aaron, Richmond, CA 94805, US
	Address for service		RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB
33 31 32	Foreign priority	PRC PRNA PRDA	US 48152 P Apr 25, 2008
33 31 32	Foreign priority	PRC PRNA PRDA	US 48500 P Apr 28, 2008
	Due date	FT FG	Apr 30, 2026 Annual fee for the 18th year Patent fees
	Patent division in charge		44
97	EP language of publication	ELANG	EN - Englisch
84	Designated EP contracting states	EDS	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR
	Published EP/WO documents	EPWOPN	Original document: EP000003348573A1 Searchable text: EP000003348573A1 Original document: EP000003348573B1 Searchable text: EP000003348573B1
43	Date of first publication	EVT	Jul 18, 2018
	Date of the first transfer into DPMAregister	EREGT	Jul 18, 2018
	Date of the (most recent) update in DPMAregister	REGT	Mar 28, 2025 (Show all update days)(Hide all update days) Mar 28, 2025 Due date: changed May 9, 2024; Mar 27, 2024; Mar 28, 2023; Mar 30, 2022; Nov 18, 2021; Oct 9, 2021; Mar 31, 2021; Mar 11, 2021; Jul 16, 2020; Jul 9, 2020; May 8, 2020; Apr 8, 2020; Apr 2, 2020; Aug 23, 2019; Jun 27, 2019 Historical data not available for this/these date(s) Jul 18, 2018 Date of the first transfer into DPMAregister

Procedural data
No.	Kind of procedure	Legal status	Date of legal/procedural status	Publication date	Alle Details anzeigen
1	Procedure relating to EP application	EPO 1st publication	Jul 18, 2018		Details anzeigen
2	Publications	Publication of a mention regarding EP 1st publication by DPMA	Aug 30, 2018	Aug 30, 2018	Details anzeigen
3	Procedure relating to EP application	EPO publication of mention regarding patent grant (beginning of opposition period)	Apr 22, 2020		Details anzeigen
4	Publications	Publication by DPMA of mention regarding EP patent grant	May 14, 2020	May 14, 2020	Details anzeigen
5	Procedure relating to EP application	No opposition to patent grant filed, or opposition proceedings at EPO completed without decision	Jan 25, 2021	Apr 15, 2021	Details anzeigen
6	New applicant/owner details	New applicant/owner details	Oct 8, 2021	Nov 18, 2021	Details anzeigen

View procedures Procedure relating to EP application (No.: 1)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to EP application
Legal/procedural status	VST	EPO 1st publication
Date of legal/procedural status	VSTT	Jul 18, 2018

View procedures Publications (No.: 2)
Criterion	Field	Content Close details
Type of procedure	VART	Publications
Legal/procedural status	VST	Publication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural status	VSTT	Aug 30, 2018
Issue number	HN	35
Year	PJ	2018
Publication date	VT	Aug 30, 2018
Type of publication	PART	Bibliographic data

View procedures Procedure relating to EP application (No.: 3)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to EP application
Legal/procedural status	VST	EPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural status	VSTT	Apr 22, 2020

View procedures Publications (No.: 4)
Criterion	Field	Content Close details
Type of procedure	VART	Publications
Legal/procedural status	VST	Publication by DPMA of mention regarding EP patent grant
Date of legal/procedural status	VSTT	May 14, 2020
Issue number	HN	20
Year	PJ	2020
Publication date	VT	May 14, 2020
Type of publication	PART	Bibliographic data
Part	HT	Part 5

View procedures Procedure relating to EP application (No.: 5)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to EP application
Legal/procedural status	VST	No opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural status	VSTT	Jan 25, 2021
Issue number	HN	15
Year	PJ	2021
Publication date	VT	Apr 15, 2021
Type of publication	PART	Bibliographic data
Part	HT	Part 3
Date of update of the procedure	REGT	Mar 31, 2021

View procedures New applicant/owner details (No.: 6)
INID	Criterion	Field	Content Close details
	Type of procedure	VART	New applicant/owner details
	Legal/procedural status	VST	New applicant/owner details
	Date of legal/procedural status	VSTT	Oct 8, 2021
	Issue number	HN	46
	Year	PJ	2021
	Publication date	VT	Nov 18, 2021
	Type of publication	PART	Bibliographic data
	Part	HT	Part 3
71/73	Applicant/owner	INH	Bioverativ Therapeutics Inc., Waltham, Mass., US; Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
71/73	Previous applicant/owner	INHF	Bioverativ Therapeutics Inc., Waltham, Mass., US, Dyax Corp., Lexington, Mass., US
	Date of update of the procedure	REGT	Nov 18, 2021